Patient Journey Guides

Preparing Alzheimer's Medical Records for a Consultation in China

The most useful Alzheimer's referral connects symptoms, everyday function, investigations, and treatment on the same timeline. A specialist needs to understand what changed before a scan or medicine was ordered, what that investigation established, and what happened afterward. A folder of isolated screenshots may conceal those relationships even when it contains many pages.

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

  • On the first page, identify the patient, date of birth, usual language, educational background, and a contact who knows their daily life well. Then describe the first noticeable changes, the approximate timing of the first assessment, major investigations, diagnostic revisions, and treatments. An approximate date should be marked as approximate. A precise but invented date makes the record less reliable.
  • An APOE result may inform a discussion of amyloid-related imaging abnormality risk during antibody treatment. It does not establish an Alzheimer's diagnosis by itself. Testing prompted by unusually young onset or a strong family pattern can address a different question about a possible genetic cause. State who recommended testing, what question it was intended to answer, and whether genetic counseling was provided.
  • Place translated summaries beside their source reports and preserve dates, units, medicine names, and test methods. Mark uncertain terminology for verification. “Possible,” “suspected,” and “cannot exclude” must not become a definite diagnosis in translation. Negative findings, decimal points, and dosing frequency deserve particular attention because a small transcription error can materially change the meaning.

Quick answer

The most useful Alzheimer's referral connects symptoms, everyday function, investigations, and treatment on the same timeline. A specialist needs to understand what changed before a scan or medicine was ordered, what that investigation established, and what happened afterward. A folder of isolated screenshots may conceal those relationships even when it contains many pages.

Full guide

The most useful Alzheimer's referral connects symptoms, everyday function, investigations, and treatment on the same timeline. A specialist needs to understand what changed before a scan or medicine was ordered, what that investigation established, and what happened afterward. A folder of isolated screenshots may conceal those relationships even when it contains many pages.

For a consultation in China, prepare a short clinical overview together with the original supporting documents. The overview helps the receiving team locate the important questions; the originals allow it to check the evidence. A translated summary should never become the only surviving version of a laboratory result, imaging interpretation, or prescription. If something is missing, identify the gap rather than filling it with a guess.

Begin with the story of the illness

On the first page, identify the patient, date of birth, usual language, educational background, and a contact who knows their daily life well. Then describe the first noticeable changes, the approximate timing of the first assessment, major investigations, diagnostic revisions, and treatments. An approximate date should be marked as approximate. A precise but invented date makes the record less reliable.

Use concrete examples of functional change. Repeating a question several times in a morning, needing someone else to arrange medicines, or becoming unable to manage a previously familiar payment can communicate more than “poor memory.” Explain what the person could do previously and whether physical disability, visual loss, language difficulty, or a change in household responsibilities could also account for the difference.

Separate sudden episodes from the longer course. If confusion worsened during a hospital admission, after a fall, or around a medicine change, record the associated circumstances and whether the person recovered. This helps clinicians consider delirium or another acute problem instead of assuming that every deterioration represents the underlying dementia advancing.

Finish the overview with the main questions for the visit. Diagnostic clarification, interpretation of a biomarker result, assessment for an antibody, and help with distressing behavior may require different information. The hospital can prioritize missing records more effectively when it understands the reason for referral.

Preserve the context of cognitive and functional assessments

Include complete reports from cognitive screening and formal neuropsychological assessment when available. Record the date, instrument, language, total and component scores, and the examiner's interpretation. Hearing, vision, fatigue, distress, acute illness, and the ability to understand instructions can all matter when interpreting performance.

Scores from different instruments should not be directly subtracted as if they measured change on the same scale. Even repeated use of one instrument requires clinical interpretation of the testing conditions. A family can arrange results chronologically, but should avoid assigning a treatment failure or a new stage solely from a fluctuation in one score.

Where available, keep scoring details and functional assessments rather than only a total printed in a brief clinic letter. Link the testing dates with observations about medicine management, finances, cooking, personal care, and communication. A stable score does not make a meaningful loss of daily independence irrelevant. Conversely, a low result obtained during an acute illness may not describe the person's usual abilities.

Obtain brain images as well as written reports

An MRI report summarizes the radiologist's findings, but a new team may need to inspect the images themselves. Ask the original imaging provider how to obtain the complete study and report. Then ask the Chinese hospital which file formats and transfer methods it accepts. A few phone photographs of a film or selected image slices may leave out the information required for a specialist interpretation.

For someone considering an anti-amyloid medicine, MRI findings have a safety role as well as a diagnostic role. Microhemorrhages, superficial siderosis, other vascular findings, and the adequacy of the available sequences may affect assessment. The treating team must decide whether an existing study is recent and suitable enough to serve as a baseline. A report saying “no major abnormality” is not proof that every relevant safety feature has been evaluated.

CT may have been part of a general dementia investigation, but it cannot replace the MRI monitoring required for these antibody treatments. If the person has an implanted device, provide its model, implantation information, and available documentation about MRI conditions. Also disclose previous difficulty completing a scan because of claustrophobia, agitation, pain, or inability to lie flat. The team needs this information before making a treatment plan that depends on repeated imaging.

Keep biomarker details beyond a positive or negative label

For amyloid PET, preserve the date, tracer, complete interpretation, and images if obtainable. For cerebrospinal fluid testing, retain the analytes, numerical values, units, reference information, laboratory, and collection date. Different methods and laboratories may use different interpretation rules. Results should not be placed on one numerical scale simply because they relate to the same disease process.

For blood testing, the product or analytical platform, specimen type, sampling date, reporting date, and result category are useful. A p-tau217 test, a p-tau181 test, and a ratio combining different biomarkers are not interchangeable records. An intermediate result should remain intermediate in the translation rather than becoming a definite positive.

The Alzheimer's Association blood biomarker guideline distinguishes between tests suitable for triage and sufficiently accurate tests that may substitute for confirmatory investigations in specified specialist settings. Its recommendations concern people with objective cognitive impairment and do not validate every marketed test for every purpose. Giving the receiving clinician the actual assay information is therefore more helpful than stating that “an Alzheimer's blood test was positive.”

If a laboratory issued an amended report or notified the family of a product problem, retain both the original and corrected material. The FDA recall record involving particular Lumipulse instructions illustrates why product identity and timing can matter. It does not mean that all Alzheimer's blood tests have been withdrawn, nor does a US record automatically establish a recall in China. The laboratory and clinical team should determine whether the individual's result needs review.

Explain why genetic testing was performed

An APOE result may inform a discussion of amyloid-related imaging abnormality risk during antibody treatment. It does not establish an Alzheimer's diagnosis by itself. Testing prompted by unusually young onset or a strong family pattern can address a different question about a possible genetic cause. State who recommended testing, what question it was intended to answer, and whether genetic counseling was provided.

For the family history, list the relationship, approximate age at symptom onset, and the diagnosis if known. Avoid labeling every elderly relative's forgetfulness as the same inherited condition. “Unknown” is an appropriate entry when reliable information is unavailable. A consumer genetics screenshot or an independently interpreted raw-data file should not be represented as a clinically confirmed diagnostic report.

Because genetic information can concern relatives as well as the patient, use the receiving institution's accepted process for consent and secure submission. The purpose is to enable clinical interpretation, not to circulate a family genetic record more widely than the consultation requires.

Reconstruct actual medicine use

For each medicine, record the generic and brand names, formulation, prescribed dose, actual schedule, start date, and whether it is still used. Note why it was changed or stopped. Include patches, liquids, injections, nonprescription sleep products, and supplements alongside ordinary tablets. If doses are frequently missed despite the prescription, say so explicitly.

When a possible adverse effect occurred, describe what happened and its timing relative to a dose increase, a new medicine, or discontinuation. Relevant experiences may include nausea, weight loss, slow pulse, fainting, rash, or behavioral changes. Document a suspected allergy with the reaction and treatment if available; not every unpleasant effect represents an allergy.

List anticoagulants and antiplatelet medicines by name and indication. “Blood thinner” is insufficient when clinicians must balance cardiovascular needs with the safety considerations of an antibody. Relevant kidney and liver results can help the team evaluate other medicines as well. Preparing a medication history is not a reason to stop or restart treatment independently.

Create a separate file for previous antibody treatment

If lecanemab or donanemab has already been given, provide the exact product, route, administered dose, and date of each treatment. Include delayed doses, interruptions, and restarts. Arrange the MRI examinations, interpretations, and treatment decisions in sequence. A statement that the patient has received several doses “without problems” cannot substitute for this history.

Any previous amyloid-related imaging abnormality, infusion reaction, or other significant event needs an event summary and supporting records. Include how the problem was assessed, whether symptoms resolved, what subsequent imaging showed, and what the original team recommended. This information may affect whether and how another clinician can continue care.

Also request the previous team's monitoring plan and handover letter. Lecanemab and donanemab have different schedules, and product information evolves. The Chinese receiving team must determine the applicable local requirements and whether additional assessment is needed. Similar treatment targets do not make the medicines automatically interchangeable, and a transfer between institutions is not simply a change in appointment location.

Make behavioral records descriptive and manageable

For night waking, resistance to personal care, shouting, or aggression, note when the behavior occurs, how often, what was happening beforehand, and what helped or worsened it. Pain, constipation, noise, difficulty understanding instructions, and the approach used during care may be relevant. A description of the situation is usually more informative than a label such as “uncooperative.”

Add information about swallowing, eating, weight change, falls, wandering, sensory difficulties, and the help needed across a normal day. Ask whether a short video would assist assessment of a particular episode, with appropriate consent and privacy protections. Recording should not displace necessary care or become an assumption that every difficult moment needs to be filmed.

The capacity of the support system also belongs in the history. If the main caregiver can no longer sustain overnight supervision or is struggling to administer medicines, the team needs to know. A technically appropriate treatment plan may fail if it assumes practical support that the household does not have.

Keep translations traceable to the original documents

Place translated summaries beside their source reports and preserve dates, units, medicine names, and test methods. Mark uncertain terminology for verification. “Possible,” “suspected,” and “cannot exclude” must not become a definite diagnosis in translation. Negative findings, decimal points, and dosing frequency deserve particular attention because a small transcription error can materially change the meaning.

Use a simple dated index so the receiving team can locate the relevant report. Identify missing pages, unavailable images, and records still being requested. If the spelling of a name differs between a medical document and the travel identity document, explain the relationship to the hospital rather than modifying the original record.

Submit records through the institution's designated channel and confirm the recipient and appropriate authorization. Avoid placing an identifiable medical history on a publicly accessible link. Requirements for sharing records and for a representative to act on a patient's behalf depend on the institutions and jurisdictions involved; a form used abroad should not be assumed to settle every requirement in China.

A well-prepared file makes uncertainty visible rather than hiding it. The hospital may accept some outside investigations, request clarification of others, and decide that a particular test must be repeated for a clinical reason. The purpose of preparation is to support that judgment and make the consultation more useful, not to guarantee that any checklist will secure a diagnosis or treatment approval in advance.

Sources

Related guides